US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist
  • 52.670
  • +0.470+0.90%
Close Oct 14 16:00 ET
  • 52.700
  • +0.030+0.06%
Post 20:01 ET
106.78BMarket Cap-16206P/E (TTM)

Bristol-Myers Squibb Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bristol-Myers Squibb Q3 2024 Estimates Date

Currency：USDOct 31, 2024

Estimate YoY
Revenue
11.24B
+2.53%
EPS
0.70
-24.70%
Analyst Rating
Hold

Oct 14, 2024

Bristol-Myers Squibb Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 18 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Feb 6, 20252024/Q4-- / 11.472B--
Oct 31, 20242024/Q3-- / 11.244B--
Jul 26, 20242024/Q212.201B / 11.522B--
Apr 25, 20242024/Q111.865B / 11.451B--
Feb 2, 20242023/Q411.477B / 11.203B--
DatePeriodRevenue/EstimateEarnings Call
Feb 6, 20252024/Q4-- / 11.472B--
Oct 31, 20242024/Q3-- / 11.244B--
Jul 26, 20242024/Q212.201B / 11.522B--
Apr 25, 20242024/Q111.865B / 11.451B--
Feb 2, 20242023/Q411.477B / 11.203B--

Unlock Free Earnings Estimates

Bristol-Myers Squibb Earnings Reports

  • 10-Q: Q2 2024 Earnings Report

    Jul 26 12:08 ET

  • 10-Q: Q1 2024 Earnings Report

    Apr 25 12:40 ET

  • Bristol-Myers Squibb | 10-K: FY2023 Annual Report

    Feb 13 12:00 ET

  • Bristol-Myers Squibb | 10-Q: Q3 2023 Earnings Report

    Oct 26, 2023 12:33 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 14, 2024

    Hold

    • Buy

      20.00%

    • Hold

      66.67%

    • Sell

      13.33%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Cancer Research
    Cancer Research
    Intraday+0.12%